Related Experiment Video
Updated: Jan 10, 2026

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
Published on: March 16, 2018
[Cross susceptibility of ototoxicity about aminoglycoside antibiotics]
J Wu1
1Military General Hospital, Jinan.
Abstract:
A familial investigation was made in three families with deafness patients caused by aminoglycoside (AMI). The results showed that there was cross susceptibility among a few AMI antibiotics. The people with familial history of deafness caused by AMI were easier to be toxic than those without familial history, even though little dose of AMI for the former, especially for children. The cross susceptibility is dominated by inheritance of matriarchal heredity and by general chromosome. The data suggest that medical history should be inquired before treatment with AMI, and patients with matriarchal heredity must be prohibited from using AMI.
Insights
Aminoglycoside (AMI) antibiotics can cause deafness, especially in children with a family history. Genetic factors, particularly maternal inheritance, increase susceptibility to AMI toxicity.
Area of Science:
- Pharmacogenetics
- Ototoxicity
- Genetic Epidemiology
Context:
- Aminoglycoside antibiotics are widely used but can cause hearing loss.
- Familial aggregation of aminoglycoside-induced deafness suggests a genetic component.
- Previous studies have indicated potential genetic predispositions to aminoglycoside ototoxicity.
Purpose:
- To investigate the genetic basis of aminoglycoside-induced deafness in three families.
- To determine the inheritance pattern of susceptibility to aminoglycoside toxicity.
- To identify specific aminoglycoside antibiotics exhibiting cross-susceptibility.
Summary:
- Familial investigation revealed cross-susceptibility among certain aminoglycoside antibiotics.
- Individuals with a family history of aminoglycoside-induced deafness showed increased susceptibility to toxicity, even at low doses.
- This susceptibility is primarily inherited maternally and influenced by general chromosomes.
- Children with a family history are particularly vulnerable to aminoglycoside toxicity.
Impact:
- Highlights the importance of inquiring about family medical history before prescribing aminoglycosides.
- Suggests prohibiting aminoglycoside use in patients with a history of maternal inheritance of deafness.
- Informs clinical practice and genetic counseling regarding aminoglycoside safety.
Related Concept Videos
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacokinetics: Drug–Drug Interactions
Estimation of k and VD of Aminoglycosides
Combined Effects of Drugs: Synergism
Such synergistic combinations...

